Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.
暂无分享,去创建一个
[1] B. Vrouenraets,et al. Thirty‐five years of isolated limb perfusion for melanoma: Indications and results , 1996, The British journal of surgery.
[2] B. Vrouenraets,et al. Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma , 1995, Melanoma research.
[3] A. Eggermont,et al. Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions. , 1995, Archives of surgery.
[4] A. Eggermont,et al. Systemic leakage during isolated limb perfusion for melanoma , 1993, The British journal of surgery.
[5] A. Eggermont,et al. Regional Isolated Limb Perfusion in Patients with Malignant Melanoma , 1993 .
[6] C. Ingvar,et al. The value of monitoring serum creatine phosphokinase following hyperthermic isolated limb perfusion for melanoma , 1993 .
[7] H. Hoekstra,et al. Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results , 1992 .
[8] C. Ingvar,et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] A. V. van Geel,et al. Functional morbidity after regional isolated perfusion of the limb for melanoma , 1989, Cancer.
[10] B. Kroon. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. , 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] A. Verhest,et al. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[12] E. V. van Slooten,et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.
[13] H. Schraffordtkoops. Prevention of neural and muscular lesions during hyperthermic regional perfusion. , 1972 .
[14] R. F. Ryan,et al. Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.